敲低着丝粒蛋白U对顺铂耐药卵巢癌细胞自我更新、顺铂耐药和Wnt/β-catenin信号活性的抑制作用

doi:10.13481/j.1671-587X.20210309

Abstract

Abstract: Objective

To investigate the effect of centromere protein U （CENPU） on cisplatin resistance of ovarian cancer（OC） cells， and to analyze its mechanism.

Methods

The expression levels of CENPU protein in the OC cells （OVCAR3 and SKOV3 cells） and cisplatin resistant OC cells （OVCAR3/DDP and SKOV3/DDP cells） were detected by Western blotting method. The OVCAR3/DDP and SKOV3/DDP cells were divided into shControl group （transfected with shControl plasmid） and CENPU short hairpin RNA plasmid（shCENPU） group （transfected with shCENPU plasmid）.The cell viabilities in two groups after stimulated with 0－100 μmol·L^－1 cisplatin for 24 h were detected by CCK-8 assay； after stimulated with 20 μmol·L^－1 cisplatin for 24 h， the apoptotic rates of cells in two groups were detected by flow cytometry； the sphere formation efficiencies （SFE） of the cells in two groups were detected by tumor sphere formation assay； the expression levels of self-renewing related gene sex determining region Y （SRY）-related high-mobility-group （HMG）-box protein-2 （Sox2）， Nanog and octamer-binding transcription factor-4 （Oct4） mRNA in the cells in two groups were detected by Real-time fluorescence quantitative PCR（RT-qPCR） method； the expression levels of Wnt/β-catenin pathway related proteins wingless type MMTV integration site family member 1 （Wnt1）， cyclinD1， c-Myc， and β-catenin in the cells in two groups were detected by Western blotting method.

Results

Compared with the OVCAR3 and SKOV3 cells， the expression levels of CENPU protein in the OVCAR3/DDP and SKOV3/DDP cells were significantly increased （P<0.05）. After treated with cisplatin， compared with shControl group， the viabilities of OVCAR3/DDP and SKOV3/DDP cells in shCENPU group were significantly decreased（P<0.05）， and the apoptotic rates were significantly increased （P<0.05）. Compared with shControl group， the SFE and the expression levels of Sox2， Nanog， and Oct4 mRNA， and the expression levels of Wnt1， cyclinD1， c-Myc， and β-catenin proteins in the OVCAR3/DDP and SKOV3/DDP cells in shCENPU group were significantly decreased（P<0.05）.

Conclusion

CENPU knockdown can inhibit the self-renewal，cisplatin resistance， and Wnt/β-catenin signaling activity in cisplatin resistant OC cells.

Key words: centromere protein U, ovarian tumor, chemotherapy resistance, self-renewal, Wnt/β-catenin signaling pathway, cisplatin

CLC Number:

R737.31

Yingjun REN, Hui ZHANG, Ying ZHOU. Inhibitory effects of centromere protein U knockdown on self-renewal, cisplatin resistance and Wnt/β-catenin signaling activity in cisplatin resistant ovarian cancer cells[J].Journal of Jilin University(Medicine Edition), 2021, 47(3): 608-614.

Figures/Tables 9

Fig. 1

Fig. 2

Tab.1

Tab.2

Tab.3

Fig. 3

Tab.4

Fig. 4

Tab.5

References

1	SIEGEL R L， MILLER K D， JEMAL A. Cancer statistics， 2020［J］. CA Cancer J Clin， 2020， 70（1）： 7-30.
2	EISENHAUER E A. Real-world evidence in the treatment of ovarian cancer ［J］.AnnOncol，2017，28（）：viii61-viii65.
3	KATSUMATA N， YASUDA M， TAKAHASHI F， et al. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer： a phase 3， open-label， randomised controlled trial［J］. Lancet， 2009， 374（9698）： 1331-1338.
4	LHEUREUX S， BRAUNSTEIN M， OZA A M. Epithelial ovarian cancer： Evolution of management in the era of precision medicine［J］. CA Cancer J Clin， 2019， 69（4）： 280-304.
5	LI H J， ZHANG H， WANG Y L. Centromere protein U facilitates metastasis of ovarian cancer cells by targeting high mobility group box 2 expression［J］. Am J Cancer Res， 2018， 8（5）： 835-851.
6	WANG X X， CHEN D G， GAO J B， et al. Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival［J］. Cancer Manag Res， 2018， 10： 6971-6984.
7	LIN S Y， LV Y B， MAO G X， et al. The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer［J］. Oncol Lett， 2018， 16（5）： 6721-6728.
8	WANG S， LIU B B， ZHANG J J， et al. Centromere protein U is a potential target for gene therapy of human bladder cancer［J］. Oncol Rep， 2017， 38（2）： 735-744.
9	HARA M， FUKAGAWA T. Critical foundation of the kinetochore： the constitutive centromere-associated network （CCAN）［J］. Prog Mol Subcell Biol， 2017， 56： 29-57.
10	PESENTI M E， PRUMBAUM D， AUCKLAND P， et al. Reconstitution of a 26-subunit human kinetochore reveals cooperative microtubule binding by CENP-OPQUR and NDC80［J］. Mol Cell， 2018， 71（6）： 923-939.
11	ISHIGURO T， OHATA H， SATO A， et al. Tumor-derived spheroids： Relevance to cancer stem cells and clinical applications［J］. Cancer Sci， 2017， 108（3）： 283-289.
12	PLAKS V， KONG N W， WERB Z. The cancer stem cell niche： how essential is the niche in regulating stemness of tumor cells？［J］. Cell Stem Cell， 2015， 16（3）： 225-238.
13	NAJAFI M， MORTEZAEE K， MAJIDPOOR J. Cancer stem cell （CSC） resistance drivers［J］. Life Sci， 2019， 234： 116781.
14	SUN J H， LUO Q， LIU L L， et al. Liver cancer stem cell markers： Progression and therapeutic implications［J］. World J Gastroenterol， 2016， 22（13）： 3547-3557.
15	KRISHNAMURTHY N， KURZROCK R. Targeting the Wnt/beta-catenin pathway in cancer： Update on effectors and inhibitors［J］. Cancer Treat Rev， 2018， 62： 50-60.
16	YANG H Y， SHEN J X， WANG Y， et al. Tankyrase promotes aerobic glycolysis and proliferation of ovarian cancer through activation of wnt/β-catenin signaling［J］. Biomed Res Int， 2019， 2019： 2686340.
17	TEEUWSSEN M， FODDE R. Wnt signaling in ovarian cancer stemness， EMT， and therapy resistance［J］. J Clin Med， 2019， 8（10）： E1658.
18	BOCCHICCHIO S， TESONE M， IRUSTA G. Convergence of Wnt and Notch signaling controls ovarian cancer cell survival［J］. J Cell Physiol， 2019， 234（12）： 22130-22143.
19	DENG S， WONG C K C， LAI H C， et al. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition［J］. Oncotarget， 2017， 8（16）： 25897-25914.

Group	Cell viability after treated with DDP
	[c_B/(μmol·L^－1)] 0	4	8	16	32	64	100
shControl	100.00±5.67	96.04±12.38	94.15±13.42	91.23±11.25	85.54±9.86	68.26±5.45	45.37±6.53
shCENPU	95.02±9.64	90.58±9.89	65.07±8.64^*	52.48 ±7.65^*	41.65±5.38^*	25.24±3.25^*	15.13±3.59^*

Group	Cell viability after treated with DDP
	[c_B/(μmol·L^－1)] 0	4	8	16	32	64	100
shControl	100.00±7.89	99.13±11.04	95.26±9.83	92.67±10.12	88.54±11.04	62.15±8.32	41.21±7.02
shCENPU	93.38±14.56	93.13±8.02	73.26±7.02^*	51.35 ±11.26^*	32.73±4.54^*	18.76±3.84^*	6.89±1.23^*

Group	Apoptotic rate
	OVCAR3/DDP cells	SKOV3/DDP cells
shControl	11.25±2.38	8.26±2.13
shCENPU	48.56±5.31	53.27±6.31
t	12.454	16.783
P	<0.05	<0.05

Group	OVCAR3/DDP cells				SKOV3/DDP cells
	SFE (η/%)	Sox2 mRNA	Nanog mRNA	Oct4 mRNA	SFE (η/%)	Sox2 mRNA	Nanog mRNA	Oct4 mRNA
shControl	12.21±2.12	1.00±0.00	1.00±0.00	1.00±0.00	10.39±1.68	1.00±0.00	1.00±0.00	1.00±0.00
shCENPU	4.25±0.94	0.15±0.06	0.45±0.08	0.53±0.05	2.96±0.73	0.31±0.03	0.21±0.05	0.36±0.04
t	8.726	19.804	7.435	6.986	10.315	9.824	13.265	9.063
P	<0.05	<0.05	<0.05	<0.05	<0.05	<0.05	<0.05	<0.05

Group	OVCAR3/DDP cells				SKOV3/DDP cells
	CyclinD1	c-Myc	Wnt1	β-catenin	CyclinD1	c-Myc	Wnt1	β-catenin
shControl	1.00±0.00	1.00±0.00	1.00±0.00	1.00±0.00	1.00±0.00	1.00±0.00	1.00±0.00	1.00±0.00
shCENPU	0.56±0.06	0.78±0.05	0.39±0.07	0.36±0.04	0.45±0.02	0.32±0.03	0.58±0.03	0.24±0.07
t	8.024	5.876	11.206	13.425	10.115	15.316	9.403	18.432
P	<0.05	<0.05	<0.05	<0.05	<0.05	<0.05	<0.05	<0.05

Inhibitory effects of centromere protein U knockdown on self-renewal, cisplatin resistance and Wnt/β-catenin signaling activity in cisplatin resistant ovarian cancer cells

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 9

References

Related Articles 15

Metrics

Comments

Recommended 10

[1]	Yu YAN,Dandan HUANG,Chunling HONG,Bowen WEI,Yuanyuan YANG,Guanghai YAN,Yilan SONG,Zhemin XIAN. Improvement effect of imperatorin on airway remodeling in bronchial asthma mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1508-1517.
[2]	Rongmian YAN,Xinting SUN,Xin GUAN,Yu CHENG,Liying HAN. Effects of KLK5 overexpression on growth of subcutaneous xenograft tumor and cisplatin sensitivity in nude mice [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1194-1203.
[3]	Yanhong MU,Yingna LI,Jianzeng LIU,Chunhong LUO,Liwei SUN,Rui JIANG. Promotional effect of CHAaHGS on hair growth and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1240-1250.
[4]	Xingxiang WANG,Ying ZHAO,Qiaotong REN,Hefei WANG,Gang PU,Chun LI. Promotive effect of M2 macrophages on epithelial-mesenchymal transition and cisplatin resistance in non-small cell lung cancer A549 cells by regulating NF-κB signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 642-652.
[5]	Kaiqi NIU,He CHANG,Guangfu LYU,Pengyu ZHENG,Xueting CHI,Jia ZHOU,Yuchen WANG,Xiaowei HUANG. Inhibitory effect of astragaloside Ⅳ on cisplatin-induced liver injury in mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 370-377.
[6]	Guangwen LONG,Qian ZHANG,Xiulin YANG,Hongpeng SUN,Chunling JI. Improvement effect of inhibiting miR-193a-5p expression on pulmonary fibrosis in rats with acute respiratory distress syndrome and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1491-1498.
[7]	Fangyang JIANG,Jing XIAO,He CHANG,Mingyang SUN,Wenjing ZHANG,Guangfu LYU,He LIN,Zhe LIN,Xiaowei HUANG,Yuchen WANG. Effect of polygonatum odoratum polysaccharide on acute kidney injury in mice induced by cisplatin and its ferroptosis mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1235-1242.
[8]	Yuxuan CAO,Wei CHEN,Chengbiao SUN,Na ZHAO,Yan WANG,Mingxin DONG,Na XU,Wensen LIU,Yongmei LI. Damage effect of VSV on vascular endothelial barrier function in vitro and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1275-1285.
[9]	Dongfang LI,Haoliang LI,Guanghui LI,Yang LI. Effect of mangiferin on hip fracture healing in rats by regulating Wnt/β-catenin signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 956-962.
[10]	Ying ZHANG,Xianxun JIANG,Zhaohui WAN. Enhancement effect of TPX2 gene silencing on chemosensitivity of bladder cancer cell line T24/DDP to cisplatin and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 346-354.
[11]	Chunyan KANG,Xiuzhi ZHANG,Huicong ZHOU,Jie CHEN. Effect of downregulating proline-rich protein 11 expression on drug resistance of esophageal cancer drug resistant cell EC9706/DDP and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 113-119.
[12]	Li JIN,Xiaohong ZHANG,Chaoyang HU,Fengzhi LI,Yongliang CUI,Yang LI,Qianqian LIU,Yanjun QIAO. Effects of quercetin on growth and lung metastasis of transplanted tumor and cell invasion, and cell migration in human lung cancer A549 cells transplanted tumor model mice and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2023, 49(4): 1018-1026.
[13]	Xiaomei HUANG,Hongwei WANG,Zhenyan HAN,Qiuyuan WEI,Sujing HUANG. Effects of lncRNA GHET1 on biological behaviors of trophoblast cells in preeclampsia through Wnt/β-catenin signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2022, 48(5): 1324-1332.
[14]	Da LI,Yanhong JIA,Zebing ZHANG,Xiufeng HAO. Preparation and evaluation of sodium alginate-locust bean gum interpenetrating polymer network hydrogel drug sustained-release system [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 809-817.
[15]	Ye TIAN, ABUDU MIJITI·Abudu Kelimu,Peng WANG,Mo SHA,Qi CUI. Effects of polarization state of tumor-associated macrophages on self-renewal ability and vasculogenic mimicry of prostate cancer stem cells [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 374-382.